Pasar al contenido principal

MULTI-BIO-TARGETS: UNA NUEVA ESTRATEGIA PARA EL MANEJO DEL ICTUS COMBINANDO BIOMARCADORES PRONOSTICOS Y NEUROPROTECTORES

PI18/00804

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2018
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Centro realización INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood biomarker changes following therapeutic hypothermia in ischemic stroke

  • Palà, Elena|||0000-0002-1074-990X
  • Penalba, Anna
  • Bustamante, Alejandro|||0000-0003-4390-8900
  • García-Berrocoso, Teresa|||0000-0001-7387-7389
  • Lamana-Vallverdu, Marcel
  • Meisel, Christian
  • Meisel, Andreas
  • van der Worp, H. Bart
  • R Macleod, Malcolm
  • Kallmünzer, Bernd
  • Schwab, Stefan
  • Montaner, Joan|||0000-0003-4845-2279
Therapeutic hypothermia is a promising candidate for stroke treatment although its efficacy has not yet been demonstrated in patients. Changes in blood molecules could act as surrogate markers to evaluate the efficacy and safety of therapeutic cooling. Blood samples from 54 patients included in the EuroHYP-1 study (27 treated with hypothermia, and 27 controls) were obtained at baseline, 24 ± 2 h, and 72 ± 4 h. The levels of a panel of 27 biomarkers, including matrix metalloproteinases and cardiac and inflammatory markers, were measured. Metalloproteinase-3 (MMP-3), fatty-acid-binding protein (FABP), and interleukin-8 (IL-8) increased over time in relation to the hypothermia treatment. Statistically significant correlations between the minimum temperature achieved by each patient in the hypothermia group and the MMP-3 level measured at 72 h, FABP level measured at 24 h, and IL-8 levels measured at 24 and 72 h were found. No differential biomarker levels were observed in patients with poor or favorable outcomes according to modified Rankin Scale scores. Although the exact roles of MMP3, FABP, and IL-8 in hypothermia-treated stroke patients are not known, further exploration is needed to confirm their roles in brain ischemia. Changes in blood molecules could act as surrogate markers to evaluate the efficacy and safety of therapeutic cooling. After evaluating a panel of 27 biomarkers including matrix metalloproteinases, cardiac, and inflammatory markers in the blood of patients treated with hypothermia and controls, MMP-3, FABP, and IL-8 increased over time in relation to the hypothermia treatment. These proteins deserve further exploration to confirm their role in brain ischemia.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Ceruletide and Alpha-1 Antitrypsin as a Novel Combination Therapy for Ischemic Stroke

  • Simats, Alba
  • Ramiro Pascual, Laura
  • Valls, Raquel
  • Ramón, Helena de
  • García-Rodríguez, Paula
  • Orset, Cyrille
  • Artigas, Laura
  • Sardon, Teresa
  • Rosell, Anna
  • Montaner, Joan
Ischemic stroke is a primary cause of morbidity and mortality worldwide. Beyond the approved thrombolytic therapies, there is no effective treatment to mitigate its progression. Drug repositioning combinational therapies are becoming promising approaches to identify new uses of existing drugs to synergically target multiple disease-response mechanisms underlying complex pathologies. Here, we used a systems biology-based approach based on artificial intelligence and pattern recognition tools to generate in silico mathematical models mimicking the ischemic stroke pathology. Combinational treatments were acquired by screening these models with more than 5 million two-by-two combinations of drugs. A drug combination (CA) formed by ceruletide and alpha-1 antitrypsin showing a predicted value of neuroprotection of 92% was evaluated for their synergic neuroprotective effects in a mouse pre-clinical stroke model. The administration of both drugs in combination was safe and effective in reducing by 39.42% the infarct volume 24 h after cerebral ischemia. This neuroprotection was not observed when drugs were given individually. Importantly, potential incompatibilities of the drug combination with tPA thrombolysis were discarded in vitro and in vivo by using a mouse thromboembolic stroke model with t-PA-induced reperfusion, revealing an improvement in the forepaw strength 72 h after stroke in CA-treated mice. Finally, we identified the predicted mechanisms of action of ceruletide and alpha-1 antitrypsin and we demonstrated that CA modulates EGFR and ANGPT-1 levels in circulation within the acute phase after stroke. In conclusion, we have identified a promising combinational treatment with neuroprotective effects for the treatment of ischemic stroke., Neurovascular Research Laboratory acknowledges funding for this project by PI15/00354 and PI18/00804 grants from Instituto Carlos III; the Spanish neurovascular research network INVICTUS PLUS (RD16/0019/0021) also from the Instituto de Salud Carlos III (co-financed by the European Regional Development Fund, FEDER); the program 2017-SGR-1427 from the Generalitat de Catalunya; and the “Advanced Neuroprotection Repurposing Drugs and Nutraceuticals for Stroke in Andalusia: NARDNIA Project,” and COMBINA2 project both funded by the Andalusian Ministry of Health (PE-0527–2019 and PY20-01351). L.R. is supported by a predoctoral fellowship grant (IFI17/00012), from Instituto de Salud Carlos III., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Blood biomarker changes following therapeutic hypothermia in ischemic stroke

  • Palà, Elena
  • Penalba, Anna
  • Bustamante, Alejandro
  • García-Berrocoso, Teresa
  • Lamana-Vallverdú, Marcel
  • Meisel, Christian
  • Meisel, Andreas
  • Worp, H. Bart van der
  • Macleod, Malcolm R.
  • Kallmünzer, Bernd
  • Schwab, Stefan
  • Montaner, Joan
Therapeutic hypothermia is a promising candidate for stroke treatment although its efficacy has not yet been demonstrated in patients. Changes in blood molecules could act as surrogate markers to evaluate the efficacy and safety of therapeutic cooling., Instituto de Salud Carlos III, Grant/Award Number: PI18/00804; European Commission; The European Union’s Seventh Framework Programme, Grant/Award Numbers: FP7/2007-2013, 278709; The Spanish Neurovascular Disease Research Network, Grant/Award Numbers: RICORS-ICTUS, RD21/0006/0007, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

  • Ramiro, Laura
  • Faura, Julia
  • Simats, Alba
  • García-Rodríguez, Paula
  • Ma, Feifei
  • Martín, Luna
  • Canals, Francesc
  • Rosell, Anna
  • Montaner, Joan
© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data., Ischemic stroke is a major cause of death and disability worldwide. Translation into the clinical setting of neuroprotective agents showing promising results in pre-clinical studies has systematically failed. One possible explanation is that the animal models used to test neuroprotectants do not properly represent the population affected by stroke, as most of the pre-clinical studies are performed in healthy young male mice. Therefore, we aimed to determine if the response to cerebral ischemia differed depending on age, sex and the presence of comorbidities. Thus, we explored proteomic and transcriptomic changes triggered during the hyperacute phase of cerebral ischemia (by transient intraluminal middle cerebral artery occlusion) in the brain of: (1) young male mice, (2) young female mice, (3) aged male mice and (4) diabetic young male mice. Moreover, we compared each group's proteomic and transcriptomic changes using an integrative enrichment pathways analysis to disclose key common and exclusive altered proteins, genes and pathways in the first stages of the disease. We found 61 differentially expressed genes (DEG) in male mice, 77 in females, 699 in diabetics and 24 in aged mice. Of these, only 14 were commonly dysregulated in all groups. The enrichment pathways analysis revealed that the inflammatory response was the biological process with more DEG in all groups, followed by hemopoiesis. Our findings indicate that the response to cerebral ischemia regarding proteomic and transcriptomic changes differs depending on sex, age and comorbidities, highlighting the importance of incorporating animals with different phenotypes in future stroke research studies., This work has been funded by Instituto de Salud Carlos III (PI18/00804) and by the European Regional Development Fund (FEDER). Neurovascular Research Laboratory takes part in the Spanish stroke research network RICORS-ICTUS. L.R is supported by a pre-doctoral fellowship from the Instituto de Salud Carlos III (IFI17/00012)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

H-FABP as a Biomarker in Transient Ischemic Attack

  • Guamán-Pilco, Daisy R.
  • Chocano Navarro, Elvira
  • Palà, Elena
  • Lamana-Vallverdú, Marcel
  • Penalba, Anna
  • García-Rodríguez, Paula
  • Rubiera, Marta
  • Bustamante, Alejandro
  • Rovira, Alex
  • Pérez-Sánchez, Soledad
  • Azurmendi, Leire
  • Reymond, Sandrine
  • Sánchez, Jean-Charles
  • Montaner, Joan
Data access statement: Is not available to the general public., The study investigates the utility of heart fatty-acid binding protein (H-FABP) in distinguishing TIA from mimics. Data from 175 patients from the StrokeChip multicenter study was retrospectively analyzed. H-FABP level was measured using a rapid point-of-care test. Findings revealed that H-FABP levels were higher in individuals with TIA compared to mimics [3.10 ng/mL (IQR 2.13-4.78) vs. 1.70 ng/mL (IQR 1.23-2.38)] (p < 0.001). The diagnostic performance of H-FABP, assessed using the area under the curve operating characteristic curve (AUC) was 0. 83 (95% CI = 0.76-0.90) for the final model, indicating good discriminative ability. The PanelomiX determined that a combined cutoff of > 1.85 ng/ml for H-FABP, age > 42.5 years, and baseline NIHSS > 3.5 had a 100% of sensitivity and 23.30% of specificity. The study suggests that H-FABP has potential as a TIA diagnostic biomarker. The rapid application of POCT's for H-FABP measurement supports its potential use in emergency departments and primary care settings., The first study (StrokeChip) was supported by the research project IDI20130009. Development, design, and validation of a Laboratory-on-a-chip tool for the early diagnosis of stroke and its differentiation from analogous pathologies, of the Center for the Development of Industrial Technology (CDTI). The Neurovascular Research Laboratory of the Vall d'Hebron Research Institute participates in the Spanish stroke research network RICORS (RD16/0019/00021) and received funding from Instituto de Salud Carlos III (ISCIII) DTS14/00004, PI18/00804, co-financed by the European Regional Development Fund (FEDER), for stroke biomarker research. The funders had no role in the study design or conduction., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A Panel of Blood Biomarkers for the Diagnosis of Transient Ischemic Attacks

  • Guamán-Pilco, Daisy R.
  • Palà, Elena
  • Lamana-Vallverdú, Marcel
  • Penalba, Anna
  • García-Rodríguez, Paula
  • Rubiera, Marta
  • Bustamante, Alejandro
  • Pérez-Sánchez, Soledad
  • Montaner, Joan
Accurate diagnosis of transient ischemic attacks (TIAs) is challenging. This study was aimed at analyzing blood biomarkers to distinguish TIAs from mimics. The levels of eight candidate biomarkers were measured in 234 patients with suspected TIA, 103 of whom had TIA and 131 of whom had mimics. We compared the groups, examined the effects of the biomarkers via logistic regression, compared models with likelihood ratio tests, assessed predictive accuracy with receiver operating characteristic analysis, and optimized cutoff values with the PanelomiX algorithm. ApoC-III, IL-6, and vWF were the most effective biomarkers in discriminating TIAs from mimics after adjustment for clinical variables. The area under the curve was 0.73 for ApoC-III; 0.74 for IL-6; 0.74 for vWF; and 0.72 for the clinical model. The likelihood ratio test indicated that these biomarkers showed better fit than the clinical model: Apo-CIII (P ≤ 0.031), IL-6 (P ≤ 0.030), and vWF (P ≤ 0.040). With the PanelomiX algorithm, a model incorporating biomarker thresholds (Apo-CIII >132.29 ng/mL, IL-6 >5.45 pg/mL, vWF <280.09%, NIHSS score >4.5, and age >41.5 years) achieved a sensitivity of 100% and a specificity of 28% in distinguishing TIAs from mimics. These findings suggest that combining blood biomarkers with clinical data might potentially enhance TIA diagnosis., The Neurovascular Research Laboratory of the Vall d’Hebron Research Institute, which participates in the Spanish stroke research network RICORS (RD16/0019/00021), received funding from Instituto de Salud Carlos III (ISCIII) DTS14/00004, PI18/00804, and was co-financed by the European Regional Development Fund (FEDER) for stroke biomarker research. The funders had no role in the study design or conduct. The StrokeChip study was supported by the research project IDI20130009 (Development, design, and validation of a Laboratory-on-a-chip tool for the early diagnosis of stroke and its differentiation from analogous pathologies) at the Center for the Development of Industrial Technology (CDTI)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Blood Biomarkers to Predict Long-Term Mortality after Ischemic Stroke

  • Ramiro Pascual, Laura
  • Quintana Luque, Manuel
  • Garcia Rodriguez, Paula
  • Santamarina Pérez, Estevo
  • Alvarez Sabin, José
  • Bustamante Rangel, Alejandro
  • Montaner Villalonga, Joan
  • Abraira del Fresno, Laura
Biomarcador; Endostatina; Accident cerebrovascular isquèmic, Biomarcador; Endostatina; Accidente cerebrovascular isquémico, Biomarker; Endostatin; Ischemic stroke, Stroke is a major cause of disability and death globally, and prediction of mortality represents a crucial challenge. We aimed to identify blood biomarkers measured during acute ischemic stroke that could predict long-term mortality. Nine hundred and forty-one ischemic stroke patients were prospectively recruited in the Stroke-Chip study. Post-stroke mortality was evaluated during a median 4.8-year follow-up. A 14-biomarker panel was analyzed by immunoassays in blood samples obtained at hospital admission. Biomarkers were normalized and standardized using Z-scores. Multiple Cox regression models were used to identify clinical variables and biomarkers independently associated with long-term mortality and mortality due to stroke. In the multivariate analysis, the independent predictors of long-term mortality were age, female sex, hypertension, glycemia, and baseline National Institutes of Health Stroke Scale (NIHSS) score. Independent blood biomarkers predictive of long-term mortality were endostatin > quartile 2, tumor necrosis factor receptor-1 (TNF-R1) > quartile 2, and interleukin (IL)-6 > quartile 2. The risk of mortality when these three biomarkers were combined increased up to 69%. The addition of the biomarkers to clinical predictors improved the discrimination (integrative discriminative improvement (IDI) 0.022 (0.007–0.048), p < 0.001). Moreover, endostatin > quartile 3 was an independent predictor of mortality due to stroke. Altogether, endostatin, TNF-R1, and IL-6 circulating levels may aid in long-term mortality prediction after stroke., This work has been funded by Instituto de Salud Carlos III (PI18/00804) and by La Fundació La Marató (Reg. 84/240 proj. 201702). Neurovascular Research Laboratory takes part in the Spanish stroke research network INVICTUS+ (RD16/0019/0021). L.R. is supported by a pre-doctoral fellowship from the Instituto de Salud Carlos III (IFI17/00012).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood Biomarkers to Predict Long-Term Mortality after Ischemic Stroke

  • Ramiro, Laura|||0000-0002-4121-4609
  • Abraira del Fresno, Laura|||0000-0002-5119-7929
  • Quintana, Manuel|||0000-0003-0288-9088
  • García-Rodríguez, Paula|||0000-0001-6596-8002
  • Santamarina Perez, Estevo|||0000-0003-1915-0335
  • Álvarez Sabín, José|||0000-0002-8054-9209
  • Zaragoza, Josep
  • Hernández-Pérez, María|||0000-0001-8279-7954
  • Ustrell, Xavier
  • Lara-Rodríguez, Blanca|||0009-0003-4534-9687
  • Terceño, Mikel|||0000-0001-5532-5329
  • Bustamante, Alejandro|||0000-0003-4390-8900
  • Montaner, Joan|||0000-0003-4845-2279
Stroke is a major cause of disability and death globally, and prediction of mortality represents a crucial challenge. We aimed to identify blood biomarkers measured during acute ischemic stroke that could predict long-term mortality. Nine hundred and forty-one ischemic stroke patients were prospectively recruited in the Stroke-Chip study. Post-stroke mortality was evaluated during a median 4.8-year follow-up. A 14-biomarker panel was analyzed by immunoassays in blood samples obtained at hospital admission. Biomarkers were normalized and standardized using Z -scores. Multiple Cox regression models were used to identify clinical variables and biomarkers independently associated with long-term mortality and mortality due to stroke. In the multivariate analysis, the independent predictors of long-term mortality were age, female sex, hypertension, glycemia, and baseline National Institutes of Health Stroke Scale (NIHSS) score. Independent blood biomarkers predictive of long-term mortality were endostatin.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Influence of sex, age and diabetes on brain transcriptome and proteome modifications following cerebral ischemia

  • Ramiro, Laura|||0000-0002-4121-4609
  • Faura, Júlia|||0000-0002-8436-1377
  • Simats Oriol, Alba|||0000-0002-0415-1135
  • García-Rodríguez, Paula|||0000-0001-6596-8002
  • Ma, Feifei|||0000-0003-1321-5564
  • Martín, Luna
  • Canals, Francesc|||0000-0002-0650-1135
  • Rosell Novel, Anna|||0000-0003-1082-3599
  • Montaner, Joan|||0000-0003-4845-2279
The online version contains supplementary material available at 10.1186/s12868-023-00775-7.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Blood-Based Biomarkers to Search for Atrial Fibrillation in High-Risk Asymptomatic Individuals and Cryptogenic Stroke Patients

  • Palà, Elena|||0000-0002-1074-990X
  • Bustamante, Alejandro|||0000-0003-4390-8900
  • Pagola, Jorge|||0000-0002-0725-1369
  • Juega, Jesus|||0000-0003-1309-0730
  • Francisco Pascual, Jaume|||0000-0002-8841-2581
  • Penalba, Anna
  • Rodriguez, Maite
  • De Lera Alfonso, Mercedes|||0000-0002-3954-9071
  • Arenillas, Juan F.|||0000-0001-7464-6101
  • Cabezas, Juan Antonio
  • Pérez-Sánchez, Soledad|||0000-0002-8940-9763
  • Moniche, Francisco|||0000-0001-8613-2909
  • de Torres-Chacón, Reyes
  • González-Alujas, Teresa
  • Clua Espuny, Jose Luis|||0000-0002-6508-5741
  • Ballesta-Ors, Juan|||0000-0002-0971-0936
  • Ribas, Domingo
  • Acosta Vélez, Juan Gabriel
  • Pedrote, Alonso
  • Gonzalez-Loyola, Felipe|||0000-0003-2947-5520
  • Gentile Lorente, Delicia
  • Muñoz, Miguel-Angel|||0000-0002-4083-3248
  • Molina, Carlos A.|||0000-0001-6058-6259
  • Montaner, Joan|||0000-0003-4845-2279
Atrial fibrillation (AF) increases the risk of ischemic stroke in asymptomatic individuals and may be the underlying cause of many cryptogenic strokes. We aimed to test the usefulness of candidate blood-biomarkers related to AF pathophysiology in two prospective cohorts representative of those populations. Two hundred seventy-four subjects aged 65-75 years with hypertension and diabetes from the AFRICAT cohort, and 218 cryptogenic stroke patients aged.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Blood Biomarkers to Predict Long-Term Mortality after Ischemic Stroke

  • Ramiro Pascual, Laura
  • Quintana Luque, Manuel
  • Garcia Rodriguez, Paula
  • Santamarina Pérez, Estevo
  • Alvarez Sabin, José
  • Bustamante Rangel, Alejandro
  • Montaner Villalonga, Joan
  • Abraira del Fresno, Laura
Biomarcador; Endostatina; Accident cerebrovascular isquèmic, Biomarcador; Endostatina; Accidente cerebrovascular isquémico, Biomarker; Endostatin; Ischemic stroke, Stroke is a major cause of disability and death globally, and prediction of mortality represents a crucial challenge. We aimed to identify blood biomarkers measured during acute ischemic stroke that could predict long-term mortality. Nine hundred and forty-one ischemic stroke patients were prospectively recruited in the Stroke-Chip study. Post-stroke mortality was evaluated during a median 4.8-year follow-up. A 14-biomarker panel was analyzed by immunoassays in blood samples obtained at hospital admission. Biomarkers were normalized and standardized using Z-scores. Multiple Cox regression models were used to identify clinical variables and biomarkers independently associated with long-term mortality and mortality due to stroke. In the multivariate analysis, the independent predictors of long-term mortality were age, female sex, hypertension, glycemia, and baseline National Institutes of Health Stroke Scale (NIHSS) score. Independent blood biomarkers predictive of long-term mortality were endostatin > quartile 2, tumor necrosis factor receptor-1 (TNF-R1) > quartile 2, and interleukin (IL)-6 > quartile 2. The risk of mortality when these three biomarkers were combined increased up to 69%. The addition of the biomarkers to clinical predictors improved the discrimination (integrative discriminative improvement (IDI) 0.022 (0.007–0.048), p < 0.001). Moreover, endostatin > quartile 3 was an independent predictor of mortality due to stroke. Altogether, endostatin, TNF-R1, and IL-6 circulating levels may aid in long-term mortality prediction after stroke., This work has been funded by Instituto de Salud Carlos III (PI18/00804) and by La Fundació La Marató (Reg. 84/240 proj. 201702). Neurovascular Research Laboratory takes part in the Spanish stroke research network INVICTUS+ (RD16/0019/0021). L.R. is supported by a pre-doctoral fellowship from the Instituto de Salud Carlos III (IFI17/00012).